在败血症休克中出现免疫代谢混乱
Deepmala Shrestha1, Bishnu D Pant1, Sanjoy Roychowdhury1
1Inflammation and Immunity, Cleveland Clinic Lerner Research Institute, 9500 Euclid Avenue, Cleveland, OH 44195, United States.
Journal of leukocyte biology
|September 28, 2024
概括
败血性休克会导致由于代谢变化而导致免疫抑制. 感染性休克患者的血代谢物累积改变了免疫细胞的反应,导致内毒素耐受性和感染风险增加.
科学领域:
- 免疫学 免疫学 免疫学
- 代谢学 代谢学 代谢学
- 关键护理医学 关键护理医学
背景情况:
- 败血性休克的死亡率很高,其特点是免疫系统的调节失调,从超炎症转变为低炎症.
- 低炎症增加了对二次感染的易感性,但血代谢产物在这个阶段的作用尚不清楚.
- 了解代谢变化对于管理败血症休克的免疫抑制至关重要.
研究的目的:
- 为了研究积累的血代谢物的免疫细胞功能的影响,在性休克的低炎症阶段.
- 为了确定特定的代谢物是否会影响周围血液单核细胞 (PBMCs) 的炎症反应.
- 为了确定与败血症休克中内毒素耐受性相关的代谢特征.
主要方法:
- 在全血中分析了TNF蛋白对脂聚糖化物 (LPS) 刺激的反应,来自败血症休克患者和健康对照组.
- 进行了血代谢分析,以确定在败血症休克中积累的代谢物.
- 在体外暴露健康对照PBMCs各种代谢物,并评估其LPS诱导的炎症反应.
主要成果:
- 败血性休克患者表现出内毒素耐受性,与高调节TNF蛋白的健康对照不同.
- 在败血性冲击等离子体中观察到碳水化合物,氨基酸,脂肪酸,胺,斯芬戈米林和TCA循环代谢物的显著积累.
- 在体外,一些代谢物被抑制,而另一些代谢物上调调节了PBMC对LPS的炎症反应.
结论:
- 在败血症休克中耐受性内毒素表型与广泛的血代谢物积累有关.
- 这些累积的代谢物显著调节循环免疫细胞的免疫反应.
- 代谢失调在性休克中所见的免疫抑制中起着根本性的作用,可能导致二次感染.
相关概念视频
Nephrotic Syndrome I : Introduction
2
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
2
Myocarditis I: Introduction
2
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
2
Hypoglycemia and Glucagon
206
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
206


